今日の臨床サポート 今日の臨床サポート
関連論文:
img  5:  Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma.
 
著者: Gian Paolo Rossi, Anna Belfiore, Giampaolo Bernini, Giovambattista Desideri, Bruno Fabris, Claudio Ferri, Gilberta Giacchetti, Claudio Letizia, Mauro Maccario, Francesca Mallamaci, Massimo Mannelli, Gaetana Palumbo, Damiano Rizzoni, Ermanno Rossi, Enrico Agabiti-Rosei, Achille C Pessina, Franco Mantero, Primary Aldosteronism Prevalence in Italy Study Investigators
雑誌名: Hypertension. 2007 Aug;50(2):424-31. doi: 10.1161/HYPERTENSIONAHA.107.091827. Epub 2007 Jun 25.
Abstract/Text We performed a prospective head-to-head comparison of the accuracy of the captopril test (CAPT) and the saline infusion test (SAL) for confirming primary aldosteronism due to an aldosterone-producing adenoma (APA) in patients with different sodium intake. A total of 317 (26.9%) of the 1125 patients screened in the Primary Aldosteronism Prevalence in Italy Study underwent both CAPT and SAL. They were composed of the patients with a high aldosterone/renin ratio baseline and 1 every 4 patients without such criterion. The accuracy of post-CAPT or post-SAL plasma aldosterone values for diagnosing APA was estimated with the area under the receiver operator characteristics curves. Primary aldosteronism was found in 120 patients, of which 46 had an APA. No untoward effect occurred with either test. The area under the receiver operator characteristics curve of plasma aldosterone for both tests was higher (P<0.0001) than that under the diagonal, but the between-test difference was borderline significant (P=0.054). The optimal aldosterone cutoff value for identifying APA was 13.9 and 6.75 ng/dL for the CAPT and SAL, respectively. Even at these cutoffs, sensitivity and specificity were moderate because of overlap of values between patients with and without APA. When examined in relation to sodium intake, the accuracy of the SAL surpassed that of the CAPT in the patients with a sodium intake 7.6 g per day, the SAL offers no advantage over the easier-to-perform CAPT.

PMID 17592070  Hypertension. 2007 Aug;50(2):424-31. doi: 10.1161/HYPERTENSIONAHA.107.091827. Epub 2007 Jun 25.
戻る

さらなるご利用にはご登録が必要です。

こちらよりご契約または優待日間無料トライアルお申込みをお願いします。

(※トライアルご登録は1名様につき、一度となります)


ご契約の場合はご招待された方だけのご優待特典があります。

以下の優待コードを入力いただくと、

契約期間が通常12ヵ月のところ、14ヵ月ご利用いただけます。

優待コード: (利用期限:まで)

ご契約はこちらから